Last reviewed · How we verify
DLX105
At a glance
| Generic name | DLX105 |
|---|---|
| Sponsor | Delenex Therapeutics AG |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of DLX105-DMP in Subjects With Plaque Psoriasis (PHASE1)
- Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients (PHASE2)
- Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease (PHASE2)
- Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (PHASE1, PHASE2)
- Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |